CREATE Medicines and Amsterdam University Medical Center Launch In Vivo CAR Therapy Trial for Solid Tumors CREATE Medicines and Amsterdam UMC have commenced a pivotal trial for an innovative in vivo CAR therapy, MT-302, targeting advanced gastroesophageal cancer with promising combination treatments.

CREATE Medicines and Amsterdam University Medical Center Launch In Vivo CAR Therapy Trial for Solid Tumors #United_States #Cambridge #CREATE_Medicines #MT-302 #Amsterdam_UMC